Twelve startups are competing in **Pitch & Pour 2026** at The MedTech Conference, showcasing solutions for **military health**. The event highlights early-stage innovators developing technologies to address healthcare challenges in defense sectors.
BioFactura develops a smallpox therapeutic to address biodefense threats. Emergent BioSolutions advances an anthrax vaccine as part of its biodefense portfolio. Both companies operate within the BioHealth Capital Region (BHCR), contributing to military performance and medical care innovations.
Chibueze Ihenacho leads **ARMR Systems**, a biotechnology firm specializing in treatments for traumatic battlefield injuries. The company recently won the **Drew Wynne Foundation pitch competition** and secured funding from **TEDCO, Abell Foundation, Ecphora Capital, and the USM Maryland Momentum Fund**. Under his direction, ARMR Systems continues expanding its mission to improve survivability in combat-related medical emergencies.
TEDCO, Maryland’s technology-focused economic development organization, invests **$250,000** from its Social Impact Builder Fund into **ARMR Systems**. The company develops **hemorrhage control systems** to improve survival rates for traumatic injuries in low-resource settings where emergency medical care is delayed.
